Nearly twenty percent of AML patients carry a translocation between chromosomes 21 and chromosome 8 resulting in the formation of a chimeric oncoprotein AML1-ETO; promoting self-renewal and blocking myeloid differentiation and poor prognosis. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.